One-year outcome following biological or mechanical valve replacement for infective endocarditis

F Delahaye; VH Chu; J Altclas; B Barsic; A Delahaye; T Freiberger; DL Gordon; MM Hannan; B Hoen; SS Kanj; T Lejko-Zupanc; CA Mestres; O Pachirat; P Pappas; C Lamas; C Selton-Suty; R Tan; P Tattevin; A Wang; L Clara; M Sanchez; J Casabé; C Cortes; F Nacinovich; PF Oses; R Ronderos; A Sucari; J Thierer; S Kogan; D Spelman; E Athan; O Harris; K Kennedy; D Gordon; L Papanicolas; D Eisen; L Grigg; A Street; T Korman; D Kotsanas; R Dever; P Jones; P Konecny; R Lawrence; D Rees; S Ryan; MP Feneley; J Harkness; J Post; P Reinbott; R Gattringer; F Wiesbauer; AR Andrade; ACP de Brito; AC Guimarães; M Grinberg; AJ Mansur; RF Siciliano; TMV Strabelli; MLC Vieira; RADM Tranchesi; MG Paiva; CQ Fortes; ADO Ramos; G Ferraiuoli; W Golebiovski; C Weksler; M Santos; JA Karlowsky; Y Keynan; AM Morris; E Rubinstein; SB Jones; P Garcia; M Cereceda; A Fica; RM Mella; R Fernandez; L Franco; J Gonzalez; AN Jaramillo; S Bukovski; V Krajinovic; A Pangercic; I Rudez; J Vincelj; J Pol; B Zaloudikova; Z Ashour; A El Kholy; M Mishaal; D Osama; H Rizk; N Aissa; C Alauzet; F Alla; C Campagnac; T Doco-Lecompte; F Goehringer; JP Casalta

Journal article

One-year outcome following biological or mechanical valve replacement for infective endocarditis

F Delahaye, VH Chu, J Altclas, B Barsic, A Delahaye, T Freiberger, DL Gordon, MM Hannan, B Hoen, SS Kanj, T Lejko-Zupanc, CA Mestres, O Pachirat, P Pappas, C Lamas, C Selton-Suty, R Tan, P Tattevin, A Wang, L Clara Show all

International Journal of Cardiology | Published : 2015

DOI: 10.1016/j.ijcard.2014.10.125

Abstract

Methods and results Among 5591 patients included in the International Collaboration on Endocarditis Prospective Cohort Study, 1467 patients with definite IE were operated on during the active phase and had a biological (37%) or mechanical (63%) valve replacement. Patients who received bioprostheses were older (62 vs 54 years), more often had a history of cancer (9% vs 6%), and had moderate or severe renal disease (9% vs 4%); proportion of health care-associated IE was higher (26% vs 17%); intracardiac abscesses were more frequent (30% vs 23%). In-hospital and 1-year death rates were higher in the bioprosthesis group, 20.5% vs 14.0% (p = 0.0009) and 25.3% vs 16.6% (p <.0001), respectively. In..

View full abstract

University of Melbourne Researchers

Eugene Athan Author

Grants

Awarded by American Heart Association

Funding Acknowledgements

Dr. Wang is supported in part by AHA Mid-Atlantic Grant-in-Aid Award #12GRNT12030071.r Dr Kanj declared honoraria for talks from Pfizer, Merck, Astra Zeneca, Astellas, Biologix and research funds from Astellas.